Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

被引:188
作者
Baumann, S [1 ]
Ceglarek, U [1 ]
Fiedler, GM [1 ]
Lembcke, J [1 ]
Leichtle, A [1 ]
Thiery, J [1 ]
机构
[1] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04103 Leipzig, Germany
关键词
D O I
10.1373/clinchem.2004.047308
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Magnetic bead purification for the analysis of low-abundance proteins in body fluids facilitates the identification of potential new biomarkers by matrix-assisted laser des orption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The aims of our study were to establish a proteome fractionation technique and to validate a standardized blood sampling, processing, and storage procedure for proteomic pattern analysis. Methods: We used magnetic bead separation for proteome profiling of human blood by MALDI-TOF MS (mass range, 1000-10000 Da) and studied the effects on the quality and reproducibility of the proteome analysis of anticoagulants, blood clotting, time and temperature of sample storage, and the number of freeze-thaw cycles of samples. Results: The proteome pattern of human serum was characterized by similar to 350 signals in the mass range of 1000-10000 Da. The proteome profile showed time-dependent dynamic changes before and after centrifugation of the blood samples. Serum mass patterns differed between native samples and samples frozen once. The best reproducibility of proteomic patterns was with a single thawing of frozen serum samples. Conclusion: Application of the standardized preanalytical blood sampling and storage procedure in combination with magnetic bead-based fractionation decreases variability of proteome patterns in human serum assessed by MALDI-TOF MS. (c) 2005 American Association for Clinical Chemistry
引用
收藏
页码:973 / 980
页数:8
相关论文
共 29 条
  • [1] Toward a human blood serum proteome - Analysis by multidimensional separation coupled with mass spectrometry
    Adkins, JN
    Varnum, SM
    Auberry, KJ
    Moore, RJ
    Angell, NH
    Smith, RD
    Springer, DL
    Pounds, JG
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (12) : 947 - 955
  • [2] The use of proteomics for the assessment of clinical samples in research
    Aldred, S
    Grant, MM
    Griffiths, HR
    [J]. CLINICAL BIOCHEMISTRY, 2004, 37 (11) : 943 - 952
  • [3] Proteomics: new perspectives, new biomedical opportunities
    Banks, RE
    Dunn, MJ
    Hochstrasser, DF
    Sanchez, JC
    Blackstock, W
    Pappin, DJ
    Selby, PJ
    [J]. LANCET, 2000, 356 (9243) : 1749 - 1756
  • [4] Bondarenko PV, 1999, J LIPID RES, V40, P543
  • [5] Chan K. C., 2004, CLIN PROTEOM, V1, P101, DOI DOI 10.1385/CP:1:2:101
  • [6] Proteomic patterns in serum and identification of ovarian cancer
    Diamandis, EP
    [J]. LANCET, 2002, 360 (9327) : 170 - 170
  • [7] Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations
    Diamandis, EP
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) : 367 - 378
  • [8] Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides
    Drake, SK
    Bowen, RAR
    Remaley, AT
    Hortin, GL
    [J]. CLINICAL CHEMISTRY, 2004, 50 (12) : 2398 - 2401
  • [9] The case for early detection
    Etzioni, R
    Urban, N
    Ramsey, S
    McIntosh, M
    Schwartz, S
    Reid, B
    Radich, J
    Anderson, G
    Hartwell, L
    [J]. NATURE REVIEWS CANCER, 2003, 3 (04) : 243 - 252
  • [10] A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease
    Guillaume, E
    Zimmermann, C
    Burkhard, PR
    Hochstrasser, DF
    Sanchez, JC
    [J]. PROTEOMICS, 2003, 3 (08) : 1495 - 1499